http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SI-21702-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_41b1c8db50aa84c2abd7f1f6d9294bb4
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C311-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C303-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C311-37
filingDate 2004-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c57fb62125e0ff2d9fe8c57b50e675df
publicationDate 2005-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber SI-21702-A
titleOfInvention Preparation of amorphous form of tamsulosin
abstract In the present invention, amorphous tamsulosin hydrochloride, the process for preparation thereof by lyophilisation or spray-drying and the properties thereof are disclosed. Amorphous tamsulosin hydrochloride is useful in the preparation of pharmaceutical formulations for use particularly in the treatment of benign prostatic hyperplasia.
priorityDate 2004-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454729935
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448654791
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID129211
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552794
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426128340
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25137847
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419572244
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7010183
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454729936
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21887872
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6917671
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457282502
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7668

Total number of triples: 32.